Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-Severe Plaque Psoriasis”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02762955
What this trial is testing

Comparative Clinical Trial of Efficacy and Safety of BCD-057 and Humira® in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Biocad 344
Large-scale testing (Phase 3)Active Not RecruitingNCT06095115
What this trial is testing

JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Janssen Research & Development, LLC 684
Post-approval studies (Phase 4)Study completedNCT00932113
What this trial is testing

Mechanism of Action Study for Psoriasis

Who this might be right for
Psoriasis
Tufts Medical Center 33
Testing effectiveness (Phase 2)Study completedNCT00504270
What this trial is testing

R3421 in Patients With Moderate to Severe Chronic Plaque Psoriasis.

Who this might be right for
Psoriasis
Hoffmann-La Roche 66
Large-scale testing (Phase 3)Study completedNCT00267969
What this trial is testing

Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor Research & Development, Inc. 766
Post-approval studies (Phase 4)Study completedNCT03055494
What this trial is testing

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 102
Testing effectiveness (Phase 2)Study completedNCT03442088
What this trial is testing

Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast

Who this might be right for
Plaque Psoriasis
University Hospitals Cleveland Medical Center 28
Testing effectiveness (Phase 2)Study completedNCT03895372
What this trial is testing

Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 179
Testing effectiveness (Phase 2)Study completedNCT03614078
What this trial is testing

PRCL-02 in Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis VulgarisPlaque Psoriasis
PRCL Research Inc. 92
Large-scale testing (Phase 3)Study completedNCT01777191
What this trial is testing

Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Eli Lilly and Company 204
Post-approval studies (Phase 4)Ended earlyNCT05125679
What this trial is testing

Effect of Guselkumab on Cardiovascular Risk Surrogate Markers in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Janssen-Cilag Ltd. 15
Large-scale testing (Phase 3)Looking for participantsNCT07326813
What this trial is testing

A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
InventisBio Co., Ltd 477
Large-scale testing (Phase 3)Ended earlyNCT04305327
What this trial is testing

Efficacy and Safety of Brodalumab in Adolescents From 12 to 17 Years of Age With Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
LEO Pharma 12
Large-scale testing (Phase 3)Study completedNCT02325219
What this trial is testing

An Efficacy and Safety of CNTO 1959 (Guselkumab) in Participants With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Janssen Pharmaceutical K.K. 192
Large-scale testing (Phase 3)Study completedNCT01235442
What this trial is testing

Evaluate Efficacy, and Safety of Topical Therapy and Etanercept in Subjects With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 592
Not applicableEnded earlyNCT00184366
What this trial is testing

Classification and Characterization of Patients Treated With Efalizumab for Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Norwegian University of Science and Technology 96
Early research (Phase 1)Study completedNCT06738277
What this trial is testing

This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS).

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Biocon Biologics UK Ltd 186
Post-approval studies (Phase 4)Study completedNCT03587194
What this trial is testing

Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis

Who this might be right for
Psoriasis
Psoriasis Treatment Center of Central New Jersey 50
Large-scale testing (Phase 3)Ended earlyNCT03556202
What this trial is testing

A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,936
Testing effectiveness (Phase 2)Study completedNCT06073119
What this trial is testing

Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis

Who this might be right for
Psoriasis
Sanofi 221
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation